BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35968243)

  • 21. [Knockdown of long non-coding RNA actin filament-associated protein 1 antisense RNA1 (AFAP1-AS1) inhibits epithelial-mesenchymal transition, invasion and migration of TPC-1 papillary thyroid cancer cells].
    Fan H; Dong Q; Yu J; Yin L; Sun X; Yang X; Zhang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):54-60. PubMed ID: 33441229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
    Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
    J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
    Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
    Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer.
    Ma HW; Xi DY; Ma JZ; Guo M; Ma L; Ma DH; Li PW; Guo CA
    Dis Markers; 2020; 2020():8140989. PubMed ID: 32051698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
    Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway.
    Guo JQ; Li SJ; Guo GX
    Dig Dis Sci; 2017 Aug; 62(8):2004-2010. PubMed ID: 28451917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma.
    Hao F; Mou Y; Zhang L; Wang S; Yang Y
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29654169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma.
    Lu X; Zhou C; Li R; Liang Z; Zhai W; Zhao L; Zhang S
    Tumour Biol; 2016 Jul; 37(7):9699-707. PubMed ID: 26803513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and functions of long non-coding RNA actin filament-associated protein 1-antisense RNA1 in oral squamous cell carcinoma].
    Geng YD; Wang SB; Lu TQ; Teng W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Dec; 37(6):594-601. PubMed ID: 31875436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Wei N; Sun M; Wang W; Shao Y; Gao J; Yin P; Zhao C
    Oncol Res; 2019 Jun; 27(6):653-661. PubMed ID: 30832752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells.
    Xi J; Wang Y; Liu H
    Gene; 2020 Feb; 726():144194. PubMed ID: 31669650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA AFAP1-AS1 promoted osteosarcoma proliferation and invasion via upregulating BDNF.
    Zhao BM; Cheng FH; Cai L
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2744-2749. PubMed ID: 31002124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oridonin represses lung cancer cell proliferation and migration by modulating AFAP1-AS1/IGF2BP1.
    Chen M; Shen Y
    Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):108-113. PubMed ID: 38836673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
    Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
    Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163.
    Qiu C; Li C; Zheng Q; Fang S; Xu J; Wang H; Guo H
    Bioengineered; 2022 May; 13(5):11987-12002. PubMed ID: 35603556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer.
    Yu S; Yang D; Ye Y; Liu P; Chen Z; Lei T; Pu J; Liu L; Wang Z
    Cancer Sci; 2019 Jul; 110(7):2211-2225. PubMed ID: 31069893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.